Intervention

Philippe Pibarot, Patrizio Lancellotti, Jose Luis Zamorano, et al

Watch time: 1h 33m 18s

Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, et al

Watch time: 14h 48m 39s (16 videos)

Adrian P Banning, Jonathan Hill, Evald Høj Christiansen, et al

Watch time: 10h 40m 33s (21 videos)
Transcatheter Interventions Online 2022 - On Demand

Joost Daemen, Roxana Mehran, David Hildick-Smith, et al

AI powered CT based Non Invasive CAD testing

Derek Connolly, , , et al

Watch time: 46m 1s (3 videos)

Tullio Palmerini , Carlo Savini , Marco Di Eusanio ,

Read time: 18m

Joost Daemen, Paolo Canova,

Watch time: 4h 45m 54s (24 videos)
Logo

Gregg Stone, Colin Berry, Adrian P Banning, et al

Watch time: 54m 48s (8 videos)

Jonathan Hill, James Spratt, Charalambos Antoniades, et al

Watch time: 11h 6m 44s (20 videos)

Angela McInerney, Antonio Mangieri, James Spratt, et al

Benjamin Honton , Jacques Monsegu ,

Francesco Maisano, Anita W Asgar, , et al

Watch time: 1h 6s

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Media

Joost Daemen, ,

12-months Vessel Healing Profile Following Novel Resorbable Magnesium Scaffold Implantation: An Intravascular OCT Analysis of the BIOMAG-I Trial

Watch time: 3m 1s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
Occlutech PFO Closure Device: A Long-Term Review

Daniela Trabattoni,

Watch time: 3m 26s

Mandeep Mehra, Christian Inchaustegui,

CardioNerds @AHA23: ORBITA-2: PCI for Stable Angina

Rasha Al-Lamee, Christopher Rajkumar, Nazli Okumus, et al

Watch time: 14m 58s
View from the Thoraxcenter: AHA 23 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 12m 34s

Alexander Fanaroff,

EP 103: CCS-AMI: New Classification for Acute Myocardial Infarction with Dr Kumar

Ankur Kalra, Andreas Kumar,

Listen time: 42m 43s
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 30m 36s
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial

Michael J Reardon,

Watch time: 8m 46s

Media

Angela McInerney, Antonio Mangieri, James Spratt, et al

Philipp Lurz,

Simon Kennon, Inderpaul Birdi, Georg Lutter, et al

Simon Kennon, Stephan Achenbach, Sergio Baptista, et al

Simon Kennon, Stephan Achenbach, Sergio Baptista, et al

Simon Kennon, Jonathan Byrne, Enrico Ferrari, et al

Jeff Dahlen, Robert F Storey, Guillaume Taylor, et al

Robert Gerber, Adrian P Banning, David Hildick-Smith, et al

Philipp Lurz, Wolfgang Rottbauer, Sam Dawkins, et al

Waldemar Bojara, Volker Klauss, Hans-Joachim Lau, et al

Robert Gerber, Rachel Hubble, Nishat Jahagirdar, et al

Robert Gerber, Vijay Kunadian, Roby D Rakhit, et al

Articles

Left Main Stenosis - Where Do We Stand?

Stefan Bertog

,

Daniel Howard Steinberg

,

Nina Wunderlich

,

Jennifer Franke

,

Horst Sievert

,

Citation:

Interventional Cardiology 2010;5:10–5

DOI:

https://doi.org/10.15420/icr.2010.5.1.10
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1439
  • Downloads: Downloads 4

Interactions Between Different P2Y12 Antagonists

Natalia Dovlatova

,

Stan Heptinstall

,

Citation:

Interventional Cardiology 2008;3(1):83-4

DOI:

https://doi.org/10.15420/icr.2008.3.1.83
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 607
  • Downloads: Downloads 3

Second - versus First-generation Drug-eluting Stents

Kamal Chitkara

,

Anthony H Gershlick

,

Citation:

Interventional Cardiology 2010;5:23–6

DOI:

https://doi.org/10.15420/icr.2010.5.1.23
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 12420
  • Downloads: Downloads 27
  • Citations: 7

Stent Passivation with Silicon Carbide as a Possible Alternative to Drug-eluting Stents - A Comprehensive Review of Pre-clinical and Clinical Results

Christoph Hehrlein

,

Citation:

Interventional Cardiology 2009;4(1):60-3

DOI:

https://doi.org/10.15420/icr.2009.4.1.60
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 975
  • Downloads: Downloads 4
  • Citations: 12